199 related articles for article (PubMed ID: 26813447)
1. Bilateral hypertrophy of masseteric and temporalis muscles, our fifteen patients and review of literature.
Graziano P; Dell'Aversana Orabona G; Astarita F; Ponzo LM; Nunziata R; Salzano G; Maglitto F; Solari D; Santella A; Cappabianca M; Iaconetta G; Califano L
Eur Rev Med Pharmacol Sci; 2016; 20(1):7-11. PubMed ID: 26813447
[TBL] [Abstract][Full Text] [Related]
2. [Asymmetric hypertrophy of the masticatory muscles].
Arzul L; Corre P; Khonsari RH; Mercier JM; Piot B
Ann Chir Plast Esthet; 2012 Jun; 57(3):286-91. PubMed ID: 22455902
[TBL] [Abstract][Full Text] [Related]
3. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
Nikolis A; Enright KM; Rudolph C; Cotofana S
J Cosmet Dermatol; 2020 Jun; 19(6):1294-1300. PubMed ID: 32338450
[TBL] [Abstract][Full Text] [Related]
4. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
Arikan OK; Tan FU; Kendi T; Koc C
J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
[TBL] [Abstract][Full Text] [Related]
5. Effects of botulinum toxin type A on contouring of the lower face.
Choe SW; Cho WI; Lee CK; Seo SJ
Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
[TBL] [Abstract][Full Text] [Related]
6. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
Kim HJ; Yum KW; Lee SS; Heo MS; Seo K
Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH
J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
[TBL] [Abstract][Full Text] [Related]
8. [Chemodenervation with botulinumtoxin in masseteric hypertrophy].
Mischkowski RA; Siessegger M; Lazar F; Zöller JE
Mund Kiefer Gesichtschir; 2005 Mar; 9(2):101-8. PubMed ID: 15711991
[TBL] [Abstract][Full Text] [Related]
9. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
Ahn KY; Kim ST
Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Injections for Masseter Reduction in East Asians.
Cheng J; Hsu SH; McGee JS
Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
[TBL] [Abstract][Full Text] [Related]
11. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
Kaya B; Apaydin N; Loukas M; Tubbs RS
J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
[TBL] [Abstract][Full Text] [Related]
12. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment.
von Lindern JJ; Niederhagen B; Appel T; Bergé S; Reich RH
Plast Reconstr Surg; 2001 Feb; 107(2):327-32. PubMed ID: 11214045
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
15. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
Işeri M; Işeri PK
Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
[TBL] [Abstract][Full Text] [Related]
16. Bilateral temporalis hypertrophy.
Ali K; Sittampalam G; Malik MA
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):305-7. PubMed ID: 19836926
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A in the management of masseter muscle hypertrophy.
Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS
J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A treatment for contouring of the lower face.
Park MY; Ahn KY; Jung DS
Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
[TBL] [Abstract][Full Text] [Related]
19. Unilateral temporalis muscle hypertrophy with contralateral masseteric hypertrophy.
Ozturk E; Mutlu H; Sonmez G; Sildiroglu HO; Basekim CC; Kizilkaya E
Dentomaxillofac Radiol; 2007 Jul; 36(5):296-7. PubMed ID: 17586857
[TBL] [Abstract][Full Text] [Related]
20. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
Lee JS; Son HS; Kim BJ; Lee YW
Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
